Skip to main content
Industry News
Novavax to supply Australia with 40M COVID-19 vaccine doses

Novavax and the Australian government have agreed on a supply deal for NVX-CoV2373, Novavax's COVID-19 vaccine candidate, which involves the delivery of 40 million doses once it gains regulatory approval. Data from the two trials that tested the vaccine candidate in Australia have shown positive results so far.

Full Story: